Moffitt logo

Clinical Trials Search

Clinical Trial 19569

Cancer Type:
Interventions:AMP-514 (Durvalumab); BI 1361849; CP-675,206 (tremelimumab); Durvalumab; MEDI4736 (Durvalumab); tremelimumab

Study Type: Treatment
Phase of Study: Phase I/II
Investigators:

  • Jhanelle Gray

Call 813-745-6100
or 1-800-679-0775
Overview

Study Title

A Phase 1/2 Study of Combination Immunotherapy and mRNA Vaccine in Subjects with Non-small Cell Lung Cancer (NSCLC)

Summary

Objective